Literature DB >> 5011414

Kinetics of the elimination and neuromuscular blocking effect of d-tubocurarine in man.

M Gibaldi, G Levy, W Hayton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5011414     DOI: 10.1097/00000542-197203000-00005

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  13 in total

Review 1.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 2.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

Review 3.  Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations.

Authors:  D K Meijer; W E Mol; M Müller; G Kurz
Journal:  J Pharmacokinet Biopharm       Date:  1990-02

4.  Clinical pharmacokinetics of muscle relaxants.

Authors:  L B Wingard; D R Cook
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

5.  Model determination for use in automated control of drug dosages: application to d-tubocurarine.

Authors:  H S Bradlow; B G Sherlock; R E Thornington; E S Solomon
Journal:  Med Biol Eng Comput       Date:  1983-03       Impact factor: 2.602

Review 6.  Clinical pharmacokinetics of the non-depolarising muscle relaxants.

Authors:  M I Ramzan; A A Somogyi; J S Walker; C A Shanks; E J Triggs
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

7.  Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure.

Authors:  D R Bevan; J D D'Souza; J M Rouse; J Caldwell; R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  Kinetics of d-tubocurarine disposition and pharmacologic response in rats.

Authors:  A Morino; K Kitamura; K Katayama; M Kakemi; T Koizumi
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

9.  Neuromuscular block by circulating D-tubocurarine residue following uptake and distribution.

Authors:  E Yang; C Lee
Journal:  Can Anaesth Soc J       Date:  1977-07

10.  Clinical pharmacokinetics of pancuronium bromide.

Authors:  A A Somogyi; C A Shanks; E J Triggs
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.